Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women
Authors:
- Henry G. KaplanHKHenry G. Kaplan
- Judith A. MalmgrenJMJudith A. Malmgren
- Mary K. AtwoodMAMary K. Atwood
- 1 April 2013
- journal article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 4 (2) , 148-156
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Anthracycline Regimen Adherence in Older Patients with Early Breast CancerThe Oncologist, 2012
- Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast CancerJAMA, 2012
- Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?Journal of Clinical Oncology, 2011
- Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination TrialJournal of Clinical Oncology, 2011
- Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: Safety data from the multicentre phase 3 randomised ELDA trialCritical Reviews in Oncology/Hematology, 2008
- Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric OncologyThe Lancet Oncology, 2007
- Older Female Cancer Patients: Importance, Causes, and Consequences of UndertreatmentJournal of Clinical Oncology, 2007
- Breast Cancer Treatment of Older Women in Integrated Health Care SettingsJournal of Clinical Oncology, 2006
- Breast Cancer Treatment Guidelines in Older WomenJournal of Clinical Oncology, 2005
- Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: The M.D. Anderson experience, with long-term follow-upAnnals of Oncology, 2000